These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32922287)

  • 1. Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries-A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses.
    Jakab I; Németh B; Elezbawy B; Karadayı MA; Tozan H; Aydın S; Shen J; Kaló Z
    Front Pharmacol; 2020; 11():1203. PubMed ID: 32922287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria and Scoring Functions Used in Multi-criteria Decision Analysis and Value Frameworks for the Assessment of Rare Disease Therapies: A Systematic Literature Review.
    Zelei T; Mendola ND; Elezbawy B; Németh B; Campbell JD
    Pharmacoecon Open; 2021 Dec; 5(4):605-612. PubMed ID: 34003484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review.
    Su P; Zhi K; Xu H; Xiao J; Liu J; Wang Z; Liu Q; Yu Y; Dang H
    Front Pharmacol; 2024; 15():1245825. PubMed ID: 38720775
    [No Abstract]   [Full Text] [Related]  

  • 5. How can multi criteria decision analysis support value assessment of pharmaceuticals? - Findings from a systematic literature review.
    Kolasa K; Zah V; Kowalczyk M
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):379-391. PubMed ID: 29707985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand.
    Holtorf AP; Kristin E; Assamawakin A; Upakdee N; Indrianti R; Apinchonbancha N
    J Pharm Policy Pract; 2021 Jun; 14(1):52. PubMed ID: 34127071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework.
    Angelis A; Kanavos P
    Soc Sci Med; 2017 Sep; 188():137-156. PubMed ID: 28772164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
    Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
    Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
    Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
    Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of relevant information around non-core domains to support Multi-Criteria Decision Analysis (MCDA) for decision making.
    Bayón-Yusta JC; Gutiérrez-Iglesias A; Galnares-Cordero L; Gutiérrez-Ibarluzea I
    GMS Health Innov Technol; 2024; 18():Doc02. PubMed ID: 38655192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rapid Literature Review of Multi-Criteria Decision Support Methods in the Context of One Health for All-Hazards Threat Prioritization.
    Zhao J; Smith T; Lavigne M; Aenishaenslin C; Cox R; Fazil A; Johnson A; Sanchez J; Hermant B
    Front Public Health; 2022; 10():861594. PubMed ID: 35493347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art.
    Oliveira MD; Mataloto I; Kanavos P
    Eur J Health Econ; 2019 Aug; 20(6):891-918. PubMed ID: 31006056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review.
    Gongora-Salazar P; Rocks S; Fahr P; Rivero-Arias O; Tsiachristas A
    Value Health; 2023 May; 26(5):780-790. PubMed ID: 36436791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review.
    Lasalvia P; Prieto-Pinto L; Moreno M; Castrillón J; Romano G; Garzón-Orjuela N; Rosselli D
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):409-420. PubMed ID: 31210065
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
    Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
    BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Criteria Used for Priority-Setting for Public Health Resource Allocation in Low- and Middle-Income Countries: A Systematic Review.
    Kaur G; Prinja S; Lakshmi PVM; Downey L; Sharma D; Teerawattananon Y
    Int J Technol Assess Health Care; 2019; 35(6):474-483. PubMed ID: 31307561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).
    de Andrés-Nogales F; Cruz E; Calleja MÁ; Delgado O; Gorgas MQ; Espín J; Mestre-Ferrándiz J; Palau F; Ancochea A; Arce R; Domínguez-Hernández R; Casado MÁ;
    Orphanet J Rare Dis; 2021 Apr; 16(1):186. PubMed ID: 33902672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicriteria decision analysis (MCDA) in health care: a systematic review of the main characteristics and methodological steps.
    Frazão TDC; Camilo DGG; Cabral ELS; Souza RP
    BMC Med Inform Decis Mak; 2018 Nov; 18(1):90. PubMed ID: 30382826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.